Expert Interview
A Second Opinion: An updated look at Gilead's interim results from the ongoing ASSURE study of seladelpar for Primary Biliary Cholangitis
Ticker(s): GILDInstitution: University of Wisconsin
- Professor of Gastroenterology and Hepatology at the University of Wisconsin and Director of the Metabolic Liver Health Clinic
- Manages 80 patients with Primary Biliary Cholangitis
- Clinical Interest in PBC and currently serves as the Program Director of the Transplant Hepatology Fellowship program at UW
Can you please provide a brief introduction of your current practice, incorporating how many patients you treat from PBC?
Added By: ben_adminWhat is the current standard of care and treatment options for your patients with PBC?
Added By: ben_adminWhat are your initial thoughts on seladelpar and the ASSURE studies' data?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
